Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise (Q35026897)

5 August 2017

title

Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise (English)

1 reference

5 August 2017

5

Duncker DJ

1 reference

5 August 2017

1

Stubenitsky R

1 reference

5 August 2017

van der Weerd RW

2

1 reference

5 August 2017

Haitsma DB

series ordinal

3

1 reference

5 August 2017

Verdouw PD

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

British Journal of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

122

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

1257-1270

1 reference

Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

Control of coronary blood flow by autacoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Inotropic and vasodilating properties of amrinone depend on the mode of administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Comparison of Hepatic Extraction of Insulin and Glucagon in Conscious and Anesthetized Dogs*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Dobutamine restores the reduced efficiency of energy transfer from total mechanical work to external mechanical work in stunned porcine myocardium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Haemodynamic dose-efficacy of levosimendan in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

The Two Mechanisms of Action of Racemic Cardiotonic EMD 53998, Calcium Sensitization and Phosphodiesterase Inhibition, Reside in Different Enantiomers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Calcium sensitization as a positive inotropic mechanism in diseased rat and human heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Phosphodiesterase inhibition and Ca2+ sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Alpha 1‐adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701491

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701491

1 reference

5 August 2017

1 reference

5 August 2017

1 reference